N. Galie (Bologna, Italy), J. Pepke-Zaba (Cambridge, United Kingdom)
Tolerance of long term nitric oxide treatment in severe arterial pulmonary hypertension G. Pérez, G. Juliá, M. Ponce, E. Gorriz, J. M. Pulido, P. Cabrera (Las Palmas de Gran Canaria, Spain)
| |
Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension F. Reichenberger, N. Doughty, A. Mainwood, A. Fineberg, N. Morrell, J. Pepke-Zaba (Papworth Everard, United Kingdom)
| |
Acute effects of Sildenafil and Iloprost in pulmonary hypertension of various aetiology P. Kuehnelt, A. Meyer (Hamburg, Germany)
| |
Effects of sildenafil on incremental shuttle walking test and haemodynamics in patients with pulmonary hypertension K. Amsha, T. E. Siddons, I. Armstrong, J. C. Waterhouse, D. Fishwick, T. W. Higenbottam, D. G. Kiely (Sheffield, United Kingdom)
| |
High incidence of bacteraemia complicating iv prostaglandin therapy in patients with pulmonary hypertension K. Amsha, I. Armstrong, E. A. Taylor, R. A. Lawson, C. Bates, D. G. Kiely (Sheffield, United Kingdom)
| |
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis H. Nunes, I. Honore, M. Humbert, O. Sitbon, M. Brauner, S. Maitre, F. Capron, D. Dal Soglio, C. Lamberto, J. P. Battesti, G. Simonneau, D. Valeyre (Bobigny, Clamart, France)
| |
Clinical and autoantibody features of right-heart catheter-proven pulmonary hypertension in systemic sclerosis E. A. Renzoni, C. Fonseca, D. Mukerjee, J. G. Coghlan, J. J. Reilly, S. Veeraraghavan, D. Abraham, A. U. Wells, C. Knight, C. Bunn, K. I. Welsh, C. M. Black, R. M. du Bois (London, United Kingdom)
| |
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome J. M. Fellrath, R. Lemoine, J. D. Aubert (Lausanne, Switzerland)
| |